Sorry, Olsen posted this already
Prana Secures Key Patent for Parkinson's Drug PBT434 in the United States
MELBOURNE, AUSTRALIA, Nov 28, 2011 (MARKETWIRE via COMTEX) -- Prana Biotechnology (asx:PBT) PRAN -1.96% today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a composition of matter patent for selected 8-hydroxy quinazolinone compounds, including its lead Parkinson's Disease (PD) drug candidate,
PBT434, in the United States. The patent entitled 'Neurologically Active Compounds' also covers pharmaceutical compositions containing PBT434 and selected 8-hydroxy quinazolinone compounds.